174 related articles for article (PubMed ID: 2502519)
21. What real influence does the proto-oncogene c-myc have in OSCC behavior?
Pérez-Sayáns M; Suárez-Peñaranda JM; Pilar GD; Barros-Angueira F; Gándara-Rey JM; García-García A
Oral Oncol; 2011 Aug; 47(8):688-92. PubMed ID: 21708481
[TBL] [Abstract][Full Text] [Related]
22. Amplification and enhanced expression of cellular oncogene c-Ki-ras-2 in a human epidermoid carcinoma of the lung.
Miyaki M; Sato C; Matsui T; Koike M; Mori T; Kosaki G; Takai S; Tonomura A; Tsuchida N
Jpn J Cancer Res; 1985 Apr; 76(4):260-5. PubMed ID: 3924699
[TBL] [Abstract][Full Text] [Related]
23. Amplification of the PPFIA1 gene region on 11q13 in oral squamous cell carcinomas (OSCC).
Blessmann M; Al-Dam A; Hanken H; Assaf AT; Riecke B; Klatt J; Simon R; Sauter G; Heiland M; Kluwe L; Gröbe A
J Craniomaxillofac Surg; 2013 Dec; 41(8):845-9. PubMed ID: 23453270
[TBL] [Abstract][Full Text] [Related]
24. The amplification of c-erb-B2 in cancer-free surgical margins is a predictor of poor outcome in oral squamous cell carcinoma.
Jelovac DB; Tepavčević Z; Nikolić N; Ilić B; Eljabo N; Popović B; Čarkić J; Konstantinović V; Vukadinović M; Miličić B; Milašin J
Int J Oral Maxillofac Surg; 2016 Jun; 45(6):700-5. PubMed ID: 26708050
[TBL] [Abstract][Full Text] [Related]
25. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
[TBL] [Abstract][Full Text] [Related]
26. Gene amplification and tumor progression.
Brison O
Biochim Biophys Acta; 1993 May; 1155(1):25-41. PubMed ID: 8504129
[TBL] [Abstract][Full Text] [Related]
27. Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck.
Volling P; Jungehülsing M; Jücker M; Stützer H; Diehl V; Tesch H
Eur J Cancer; 1993; 29A(3):383-9. PubMed ID: 8398339
[TBL] [Abstract][Full Text] [Related]
28. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
Somers KD; Cartwright SL; Schechter GL
Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
[TBL] [Abstract][Full Text] [Related]
29. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
Saksela K; Bergh J; Nilsson K
J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069
[TBL] [Abstract][Full Text] [Related]
30. Role of proto-oncogene activation in carcinogenesis.
Anderson MW; Reynolds SH; You M; Maronpot RM
Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
[TBL] [Abstract][Full Text] [Related]
31. Amplification of both c-myc and c-raf-1 oncogenes in a human osteosarcoma.
Ikeda S; Sumii H; Akiyama K; Watanabe S; Ito S; Inoue H; Takechi H; Tanabe G; Oda T
Jpn J Cancer Res; 1989 Jan; 80(1):6-9. PubMed ID: 2496060
[TBL] [Abstract][Full Text] [Related]
32. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
[TBL] [Abstract][Full Text] [Related]
33. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
Burgart LJ; Robinson RA; Haddad SF; Moore SA
Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
[TBL] [Abstract][Full Text] [Related]
34. Amplifications of proto-oncogenes in ovarian carcinoma.
Bian M; Fan Q; Huang S; Ma J; Lang J
Chin Med J (Engl); 1995 Nov; 108(11):844-8. PubMed ID: 8585978
[TBL] [Abstract][Full Text] [Related]
35. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes.
Yokota J; Wada M; Yoshida T; Noguchi M; Terasaki T; Shimosato Y; Sugimura T; Terada M
Oncogene; 1988 Jun; 2(6):607-11. PubMed ID: 2838790
[TBL] [Abstract][Full Text] [Related]
37. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
[TBL] [Abstract][Full Text] [Related]
38. Copy number amplification of 3q26-27 oncogenes in microdissected oral squamous cell carcinoma and oral brushed samples from areca chewers.
Lin SC; Liu CJ; Ko SY; Chang HC; Liu TY; Chang KW
J Pathol; 2005 Aug; 206(4):417-22. PubMed ID: 15906274
[TBL] [Abstract][Full Text] [Related]
39. The ras and myc oncogenes cooperate in tumor induction in many tissues when introduced into midgestation mouse embryos by retroviral vectors.
Compere SJ; Baldacci P; Sharpe AH; Thompson T; Land H; Jaenisch R
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2224-8. PubMed ID: 2648394
[TBL] [Abstract][Full Text] [Related]
40. Amplification, rearrangement, and elevated expression of c-myc in the human prostatic carcinoma cell line LNCaP.
Nag A; Smith RG
Prostate; 1989; 15(2):115-22. PubMed ID: 2678039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
